Hepatitis B and Hepatitis C in prisons: a prevalence study.

Area of Science:

• Hepatology
• Infectious Diseases
• Public Health

Background:

• Prisons present unique challenges for infectious disease control due to communal living.
• Hepatitis B virus (HBV) and Hepatitis C virus (HCV) pose significant risks in correctional facilities.
• Risk factors include shared tools, tattooing, drug use, and sexual contact.

Purpose of the Study:

• To determine the prevalence of HBV and HCV among prisoners in Turkey.
• To compare HBV and HCV rates within the prison population to other groups.
• To inform prisoners about HBV and HCV risks and prevention.

Main Methods:

• A cross-sectional study involving 360 male prisoners from two Turkish prisons (Buca F-Type Closed and Foça Open).
• Serum samples were analyzed for HBsAg, anti-HBs, anti-HBc total, and anti-HCV using the MICROELISA method.
• Prevalence rates were calculated and compared.

Main Results:

• HBV infection (HBsAg positive) was found in 4.7% of prisoners.
• Previous vaccination against HBV was indicated in 9.1% (isolated anti-HBs positive).
• Past HBV infection (isolated anti-HBc total positive) was noted in 6.9%, and recovery (anti-HBs and anti-HBc total positive) in 16.9%.
• HCV infection was detected in 0.5% of prisoners.
• No cases of HBV and HCV coinfection were identified.

Conclusions:

• The prevalence of HBV and HCV in this study group was comparable to the general population.
• Findings should not be generalized to all prison settings.
• Routine screening and vaccination are crucial for public health within correctional facilities.